baber/WOPTO huggingface dataset:
Patent NZ-582189-A (NZ)
Title: Fluidized-bed reactor for the treatment of fluidizable substances and process herefor
Inventor: REISSER FRANZ
IPC: B01J8/18
Filed: 2008-04-29
Abstract: A fluidized-bed reactor for chemical and/or physical treatment of fluidizable substances is disclosed. The reactor comprises at least one metallic central tube (3) for introducing process gas into the reactor, a bottom (7) and a metallic container (4) mounted below the central tube (3) with a conduit (5) supplying the process gas into the container (4). The metallic container (4) has a larger diameter than the metallic central tube (3). An annular space (9) defined by a metallic outer wall (8) surrounds the central tube and one or more portions of the outer wall (8) form a unit with the wall of the metallic container (8). The metallic walls of the central tube (3), the metallic container (4) and the metallic outer wall (8) are provided with a thermal insulating coating (6).
Patent NZ-582914-A (NZ)
Title: Injection device with locking mechanism on the release mechanism for preventing movement of the syringe prior to release.
Inventor: JENNINGS DOUGLAS IVAN
IPC: A61M5/20
Filed: 2008-07-28
Abstract: An automatic injection device (110) comprising a housing (112) adapted to receive a syringe (114). The syringe has a discharge nozzle (118) and is moveable in the housing along a longitudinal axis between a retracted position and an extended position in which the discharge nozzle (118) extends from the housing through an exit aperture (128). An actuator (130) and a drive (129) act upon the syringe (114) to advance it from its retracted position to its extended position and discharge its contents through the discharge nozzle (118). A release mechanism (102) is adapted to prevent the actuator (130) acting on the drive (129) when engaged and to permit the actuator to act on the drive when disengaged. A syringe carrier (127) is adapted to support the syringe (114) as it is advanced and a locking mechanism (170) is located on the release mechanism (102) to inhibit movement of the syringe carrier (127) and syringe (114) towards the exit aperture when the release mechanism (102) is in the engaged position.
Patent NZ-587413-A (NZ)
Title: Wind Turbine enhancement system via acceleration of the incoming air
Inventor: SMYTH DAVID
IPC: F03D11/00
Filed: 2009-02-23
Abstract: 587413 The present invention is concerned with a system and method for enhancing the performance of a wind turbine, which involves injecting air from an array (12, 14) of nozzles (16) into the airflow upstream of the turbine (T) in order to reduce the turbulence and/or increase the velocity and/or control the pressure of the airflow, thereby improving the performance of the turbine.
Patent NZ-588661-A (NZ)
Title: Trichoderma atroviride sc1 in an agricultural composition for treatment of fungal infections in plants
Inventor: PERTOT ILARIA
IPC: A01N63/38
Filed: 2008-03-21
Abstract: Disclosed is use of Trichoderma atroviride SC1, CBS n°122089, as a biocontrol agent, i.e. to treat fungal diseases of plants. Also described in the present invention is an agricultural composition comprising the Trichoderma atroviride SC1 as the active principle in an effective amount. The compositions of the present invention may further comprise a second biocontrol agent and/or an additive, an emulsifier, a plant nutrient, a wetting-agent, a plant micro-nutrient or a substratum, wherein said substratum is selected from the group consisting of: a nutrient culture medium, a cereal or a derivative thereof, an amendant, a vegetable or a part thereof, peat, wood or a piece thereof, clay or barks.
Patent NZ-589542-A (NZ)
Title: Transdermal drug delivery system comprising an active agent in amorphous form and polyvinylpyrrolidone
Inventor: TANG JIASHANG
IPC: A61K9/70
Filed: 2009-05-29
Abstract: Disclosed is a transdermal drug delivery device comprising: (a) a backing film; (b) a first adhesive layer comprising a solid dispersion, said dispersion comprising: an first adhesive, a first therapeutic agent selected from scopolamine, naltrexone or a salt thereof, in amorphous form, and polyvinylpyrrolidone as a first combination polymeric stabilizing and dispersing agent comprising a hydrogen bond-forming functional group; and (c) a protective release liner; wherein the weight ratio of the polymeric stabilizing/dispersing agent to the first therapeutic agent in amorphous form is at least 0.5.
Patent NZ-592338-A (NZ)
Title: Frizzled-binding agents and uses thereof
Inventor: GURNEY AUSTIN L
IPC: A61K39/395
Filed: 2009-09-28
Abstract: Provided is an isolated antibody that specifically binds a human frizzled receptor selected from the group consisting of FZD1, FZD2, FZD5, FZD7, and FZD8, wherein the antibody comprises defined sequences of the six CDRs in heavy and light chains. Further provided are antibodies binding the specific epitopes and deposited plasmids encoding the antibodies. The antibodies are useful for treating tumours.
Patent NZ-595127-A (NZ)
Title: Stable pharmaceutical composition for atherosclerosis
Inventor: PATEL NILAMKUMARI SOMALAL
IPC: A01N43/40
Filed: 2010-02-08
Abstract: 595127 The present disclosure relates to a stable solid oral pharmaceutical multi-component composition comprising combination of blood pressure lowering drugs with lipid lowering agent/s and optionally a platelet aggregation inhibitor in a single dosage form. The blood pressure lowering agents are selected from ?-adrenergic receptor blocking agent, ACE inhibitor and diuretic. The lipid lowering agent is selected from HMG Co-enzyme-A reductase inhibitor. The pharmaceutical composition made as per present disclosure a) overcomes any drug-drug interactions, b) exhibits pharmacokinetic and pharmacodynamic profile of individual therapeutic agent, c) has minimal side effects. The invention provides multi-component composition (MCC) to increase adherences to therapy. The MCC as per present disclosure provides compositions that maintain activity of all active ingredients without significant increase in adverse event profile. The present disclosure further relates to a method of preparing the said pharmaceutical composition.
Patent NZ-595610-A (NZ)
Title: Modular decking system using pre-constructed parts with the boards connected with rails that lie over beams
Inventor: KEVIN JOHN BALMER
IPC: E04B1/18
Filed: 2011-10-06
Abstract: Disclosed is a decking component that allows pre-fabrication of the decking surface. It comprises a base frame, a series of channel shaped metallic rails and a plurality of boards arranged to provide a walking surface. The boards are fixed from underneath to the rails and the rails laid over and fastened to beams forming part of the base frame, each rail fitted against at least a top face and a side face of a corresponding one of the beams to cap the top of its respective beam and are continuous along the length of the beams. Groups of rails are orientated at right or orthogonal angles to each other.
Patent NZ-596019-A (NZ)
Title: Energy release buoyant actuator
Inventor: FIEVEZ JONATHAN PIERRE
IPC: E02B9/08
Filed: 2010-04-07
Abstract: Disclosed is a buoyant actuator (see 10, figure 1) for use in an apparatus (see 11, figure 1) for harnessing wave energy in a body of water, whereby the buoyant actuator is tethered to the apparatus. The buoyant actuator is deployed within the body of water and is responsive to wave motion in the body of water. The buoyant actuator comprises a body having a flow path extending between an open upper end and an open bottom end, and a gate means (115) for controlling flow along the flow path. The gate means comprise a plurality of closure elements configured as flaps (221) which cooperate to provide a barrier across the flow path such that the gate means block or impede the fluid flow through the body in the direction of the open upper end to the open lower end, and allow unimpeded flow in the direction of the open lower end to the open upper end. This results in slowing of the buoyant actuator during ascent and provides the advantage of controlled movement of the buoyant actuator so as to limit the pump strokes and loading on the attached apparatus for harnessing wave energy. A latch mechanism, comprising a magnetic coupling which includes magnet means (241), is provided for releasably retaining each flap in the condition providing the barrier.
Patent NZ-598192-A (NZ)
Title: Powerless double-distribution pans fertilizer distributor using a gearbox to transmit the force of the wheels to the distribution pans
Inventor: KIM WAN SOO
IPC: A01C15/00
Filed: 2009-09-11
Abstract: A powerless double-distribution fans fertilizer distributor which respectively rotates two disks by driving two wheels by traction so as to distribute a fertilizer, wherein the fertilizer distributor comprises a hopper (20) which has fertilizer discharge holes in a left and right symmetrical structure and is installed above a body frame (10) having a pulling tool in the front part, wheel shafts (30) divided by left and right which are installed below the frame in such a way that one shaft end is connected with wheels (11) and the other shaft end is placed at the central lower portion of the fertilizer 10 discharge holes (21) of the hopper (20), a clutching gear box (40) which controls the rotation of each wheel shaft, converts the horizontal rotation of wheels to an upward motion by 90 degrees, and is coupled to left and right wheel shaft ends, disk distribution fans (50) and a stirring wing (60) which are coupled to a vertically connected gear shaft (41) of the clutching gear box (40), 15 and a distribution amount control device (70) which controls distribution amount control plates (72) installed at the each fertilizer discharge holes (21) of the hopper by a lever (71).
Patent NZ-599762-A (NZ)
Title: Coated drug spheroids and uses thereof for eliminating or reducing conditions such as emesis and diarrhea
Inventor: RAO SRIPRIYA VENKATA RAMANA
IPC: A61P31/00
Filed: 2010-11-01
Abstract: The disclosure relates to an oral pharmaceutical formulation comprising coated spheroids of a kinase inhibitor such as neratinib, which formulation is designed to reduce or eliminate side effects associated with existing oral formulations of kinase inhibitors. Particularly disclosed is a pharmaceutically acceptable composition of (i) spheroid particles comprising: (a) 30-70 weight percent of an active ingredient selected from the group consisting of neratinib, bosutinib, erlotinib, sutent, tykerb, a 4-mino-3-cyanoquinoline compound and pharmaceutically acceptable salts thereof; (b) 20-30 weight percent of one or more fillers; (c) 5-15 weight percent of one or more wetting agents, said spheroid particles comprising 70-83 weight percent of the total composition; (ii) a sub-coating applied to said spheroid particles further comprising 1-4 weight percent of one or more pharmaceutically acceptable cellulose based polymers and (iii) 16-30 weight percent of one or more pharmaceutically acceptable polymers as an enteric coating applied to said sub-coating, said coating components (ii) and (iii) comprising 17-30 weight percent of the total composition.
Patent NZ-600383-A (NZ)
Title: System and method for providing an athlete with a performance profile
Inventor: MARTIN TODD
IPC: A61B5/117
Filed: 2012-05-31
Abstract: 600383 Disclosed is a system (100) for matching media content created by a third party at an athletic event with a participant in the event. A database server (106) has a user database (112) for maintaining records of users registered to access said database server (106). A processor (104) is configured to receive a listing of participants whose images appear in media content created at the athletic event and compare the listing with the registered users based on the records maintained in said user database (112). The processor (104) then generates a match list of participants whose images appear in the media content created at the athletic event and who are registered users.
Patent NZ-601238-A (NZ)
Title: Apparatus and method for distributing fluid
Inventor: KOBELT JACOB
IPC: B05B1/18
Filed: 2010-01-25
Abstract: A method and apparatus (10), such as a shower head, for distributing fluid is disclosed. Fluid is received in an opening (18) and distributed via first conduit (84) to an outlet (78, 80, 82) of a first discharge element or nozzle (14). At least some of the fluid received in the opening (18) can be selectively distributed via a second conduit (94) to an outlet (98, 100, 102, 104) of a second discharge element (16) in response to coupling and decoupling of the second discharge element (16) from the apparatus. When the second discharge element (16) is coupled, some of the fluid from the first conduit (84) is distributed into the second conduit (94) and exits via the outlet (98, 100, 102, 104). The second discharge element (16) may be a shower head while the first discharge element (16) is suitable for an additional function such as the cleaning of an internal orifice.
Patent NZ-601421-A (NZ)
Title: A garment, in particular a compression garment for medical use
Inventor: CLEMENDOT OLIVIER
IPC: A61F13/08
Filed: 2011-03-23
Abstract: 601421 A garment 10 has a knitted, circumferentially-extending welt portion having an anti-slip zone 50 with a high friction yarn integrally formed on an inner face of a main garment portion 11 such that the high friction yarn contacts a wearer's skin to increase the anti-slip properties of the garment. A method of constructing the garment is also disclosed.
Patent NZ-603380-A (NZ)
Title: Reinforced cross-laminated bulk container
Inventor: PATRICKUS MARTY
IPC: B31B50/16
Filed: 2011-03-10
Abstract: 603380 Disclosed is a reinforced cross laminated bulk container (10) made of corrugated paperboard for containing fluid products. The container (10) has a rectangular configuration. The container (10) comprises an outer corrugated component which has opposing sidewalls (12, 13, 14, 15) and end walls joined together along vertical scores at corners (27). The sidewalls (12, 13, 14, 15) and end walls have top, bottom and side edges. The outer component has corrugations which run in a first direction. An inner corrugated liner is laminated to the outer component and has opposing sidewalls and end walls joined along vertical scores at corners (27) of the container (10). The sidewalls and end walls have top, bottom and side edges substantially coterminous with the top, bottom and side edges of the respective side and end walls of the outer component. The inner lining has corrugations which run in a second direction, perpendicular to the first direction. The outer component and inner liner each have at least one reinforcing strand therein which extends perpendicular to the corrugations. The sidewalls (12, 13, 14, 15) have a greater width dimension than the end walls. The at least one reinforcing strand in the outer component extends horizontally and the at least one reinforcing strand in the inner liner extends vertically substantially midway between opposite top and bottom edges thereof. The at least one reinforcing strand in the inner liner comprises at least one reinforcing strand extending vertically in each of the sidewalls substantially midway between opposite side edges thereof. The at least one reinforcing strand comprises a plurality of reinforcing strands in each of the inner liner and the outer component.
Patent NZ-607345-A (NZ)
Title: Patient circuit for improved support delivery
Inventor: EL-SHAMMAA MICHAEL
IPC: A61M39/08
Filed: 2011-08-10
Abstract: 607345 A patient circuit (300) for delivering improved support to a patient, the patient circuit comprising: at least one limb (102) comprising: a nonconfigurable region (302) defining a first interior flow passage having a first end and a second end, and a heating wire disposed within the first interior flow passage, the heating wire having a first end (306) and a second end corresponding to the first and second ends of the nonconfigurable region; and a configurable region (112) defining a second interior flow passage between an inlet, and an outlet that is coupled to the patient. The second end of the nonconfigurable region is slidably coupled to the inlet of the configurable region and the configurable region is adjustable (308, 310) so as to adjust a distance from the second end of the heating wire through the second interior flow passage to the patient.
Patent NZ-623922-A (NZ)
Title: Novel tricyclic compounds
Inventor: WOLLER KEVIN R
IPC: C07D513/14
Filed: 2009-06-09
Abstract: Disclosed herein are fused tricyclic compounds of formula (I), wherein the substituents are as defined within the specification, processes for their preparation, compositions comprising said compounds and uses thereof. Said compounds are useful for modulating kinase activity. Examples of specifically preferred compounds include: 1-(2-methylcyclohexyl)-6H-pyrrolo[2,3-e][1,2,4]triazolo[4,3-a]pyrazine; cis-4-(6H-pyrrolo[2,3-e][1,2,4]triazolo[4,3-a]pyrazin-1-yl)cyclohexanamine hydrochloride; 1-cyclohexyl-6H-imidazo[1,5-a]pyrrolo[2,3-e]pyrazine; 7-(5-methoxy-1-methyl-1H-indol-3-yl)-6H-imidazo[1,5-a]pyrrolo[2,3-e]pyrazine; 7-cyclohexyl-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazine; 8-cyclohexyl-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazine; 1-methyl-7-(3-(methylsulfonyl)phenyl)-1,6-dihydropyrazolo[3,4-d]pyrrolo[2,3-b]pyridine; 1-cyclobutyl-3,6-dihydropyrazolo[4,3-d]pyrrolo[2,3-b]pyridine; 1-(tetrahydro-2H-pyran-4-yl)-3,6-dihydropyrazolo[4,3-d]pyrrolo[2,3-b]pyridine, etc.
Patent NZ-707424-A (NZ)
Title: Table game system
Inventor: SHIGETA YASUSHI
IPC: G07F17/32
Filed: 2013-07-08
Abstract: A table game system is provided that includes a plurality of association tables, each of which makes it possible to obtain the correlation between codes attached to shuffled playing cards and the ranks thereof, and prevents the correlation between the codes of the shuffled playing cards and the ranks thereof from being known by a person who intends to commit cheating by changing the association table used as appropriate. A card shoe apparatus 2 of the table game system of the present invention includes a barcode reader 100 that reads a barcode 3 attached to a shuffled playing card set 1s, and thereby reads a shuffled card ID that can uniquely identify the shuffled playing card set 1s. The shuffled card ID of the shuffled playing cards to be used is subjected to a process of association to identify one of association table numbers (T1 to T10) or database numbers, and the rank and the suit of a card 1 that are attached to the card 1 are identified based on a code C with an association table (T3). If the code C does not match a code defined in the association table (T3), an error occurs and it is determined that cheating may be committed.
Patent NZ-707513-A (NZ)
Title: Gas delivery device and system
Inventor: BATHE DUNCAN P
IPC: G05D7/06
Filed: 2011-01-06
Abstract: A gas delivery system including a gas delivery device (100), a control module (200) and a gas delivery mechanism is disclosed. An exemplary gas delivery device includes a valve (107) assembly with a valve and circuit including a memory, a processor and a transceiver in communication with the memory. The memory may include gas data such as gas identification, gas expiration and gas concentration. The transceiver on the circuit of the valve assembly may send wireless optical line - of - sight signals (300) to communicate the gas data to the control module. Exemplary gas delivery mechanisms include a ventilator (400) and a breathing circuit (410). Methods of administering gas are also described. The gas date is compared to patient data to verify the correct therapy is being administered. An alarm may indicate when the verification process discovers a discrepancy. Communication between the valve and controller is by way of optical line-of-sight transmission.
Patent NZ-707637-A (NZ)
Title: Signal biomarkers
Inventor: PEMBERTON CHRISTOPHER JOSEPH
IPC: C12P21/08
Filed: 2011-07-19
Abstract: Discloses an isolated polypeptide selected from SEQ ID NO: 5 and/or 6, an isolated binding agent which selectively binds to SEQ ID NO: 5 and/or 6, and related methods for predicting, diagnosing or monitoring a cardiac disorder or renal disease, wherein the SEQ IDs relate to CNP signal peptide and are defined in the complete specification.
Patent NZ-709984-A (NZ)
Title: Nutritional compositions containing a peptide component with adiponectin stimulating properties and uses thereof
Inventor: ROMACHO TANIA
IPC: A61K38/08
Filed: 2014-03-11
Abstract: The present disclosure relates to nutritional compositions including a protein equivalent source that includes a peptide component comprising selected peptides. The protein equivalent source may further include intact protein, hydrolyzed protein, including partially hydrolyzed protein, or combinations thereof. The disclosure further relates to methods of promoting healthy body weight in a target subject by stimulating adiponectin levels by providing the nutritional compositions disclosed herein to a target subject, which includes a pediatric subject.
Patent NZ-712106-A (NZ)
Title: Pharmaceutical composition, methods for treating and uses thereof
Inventor: WOERLE HANS-JUERGEN
IPC: A61K31/155
Filed: 2014-04-16
Abstract: The present invention relates to the SGLT-2 inhibitor, empagliflozin, optionally in combination with one or more other therapeutic substances, in the manufacture of a medicament for delaying the progression of chronic kidney disease in a patients with type 2 diabetes mellitus and stage 3 chronic kidney disease, where empagliflozin is formulated for oral administration in a total daily amount of 10mg or 25mg.
Patent NZ-713792-A (NZ)
Title: Antimicrobial compositions and methods for their production
Inventor: O’FLAHERTY VINCENT
IPC: A61P31/00
Filed: 2014-04-29
Abstract: This invention relates to a method for preparing compositions for preventing or treating microbial infections, compositions suitable for use in such treatments and methods for treatment or prevention of infections. One such composition finds particular use in treating mastitis in ruminants. The composition is administered into the udder of an animal as a highly effective treatment for mastitis, or as a prophylactic therapy, by means of an intra-mammary infusion. The milk produced by the animal, during treatment using the composition and method of the invention, is free of residues, such as antibiotics, antimicrobial agents or antimicrobial proteins, which could affect its suitability for drinking or in the production of milk products, such as cheese or yoghurt. The compositions and methods arc also useful in treating and preventing lung infections; and infections in burns and wounds; and other infections caused by biofilms. The compositions may also be used on medical devices lo prevent infection.
Patent NZ-717890-A (NZ)
Title: Methods and systems for identifying and treating anti-progestin sensitive tumors
Inventor: GILLES ERARD
IPC: G01N33/74
Filed: 2012-10-04
Abstract: Discloses the use of an anti-progestin composition in the preparation of a medicament for the treatment of a tumor susceptible to growth inhibition by one or more anti-progestin(s), wherein the tumor is identified as susceptible to growth inhibition by one or more anti-progestin(s) wherein a) a tissue sample suspected of being tumorigenic from a patient is exposed to an anti-progesterone receptor antibody; b) flow cytometry is performed on the tissue sample to identify progesterone receptor positive cells; c) high magnification microscopy is used to identify activated progesterone receptor foci in the progesterone receptor positive cells; and d) the focal binding distribution of the progesterone receptor in nuclei of cells from the tissue is determined, wherein if the focal binding distribution is greater than 5% of the progesterone receptor positive cells in the tissue sample with an A or AD binding pattern, then the tumor is determined to be susceptible to growth inhibition by one or more anti-progestin(s).